FDA Approves First Treatment for Common Type of Post-Transplant Infection That Is Resistant to Other Drugs
Approval Is for Cytomegalovirus, a Type of Herpes Virus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.